Biote (BTMD) Preferred Stock Liabilities (2021 - 2022)
Biote (BTMD) posted quarterly Preferred Stock Liabilities of $317.5 million for Q1 2022, little changed year-over-year from $317.5 million in Q1 2021, and little changed quarter-over-quarter from $317.5 million in Q4 2021.
Biote (BTMD) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends
Biote's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $317.5 million for Q1 2022.
- In Q1 2022, Preferred Stock Liabilities changed 0.0% year-over-year to $317.5 million; the TTM figure through Mar 2022 stood at $317.5 million (changed 0.0% YoY), while the FY2021 annual figure was $317.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2022 stood at $317.5 million, roughly flat from $317.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $317.5 million in Q2 2021, with the low at $317.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Biote | 61.98 Mn | 58.05 Mn | 28.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 317.50 Mn |
| Dec 31, 2021 | 317.50 Mn |
| Sep 30, 2021 | 317.50 Mn |
| Jun 30, 2021 | 317.50 Mn |
| Mar 31, 2021 | 317.50 Mn |